Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Health & wellness/
  4. Psyched about the eclipse? What you need to know to protect your eyes and watch it safely

Psyched about the eclipse? What you need to know to protect your eyes and watch it safely

On August 21, the U.S. will witness the first total eclipse of the sun in 40 years. In this video, get tips from a Johnson & Johnson expert on how to safeguard your eyes—and enjoy the one-of-a-kind celestial event.

On Monday, August 21, a total eclipse of the sun will be visible in parts of the continental U.S. for the first time in almost 40 years as the moon completely covers it—and observers in all states will experience at least a partial eclipse.

Because this phenomenon is so rare—the next total eclipse won’t occur in the U.S. until 2024—Americans across the country are clamoring to watch. And there’s no reason not to—as long as you do so safely: Even when blocked by the moon, the sun’s rays, both visible and invisible, can cause severe and permanent damage to the eyes.

So before you check out the eclipse, check out this video—featuring safe viewing tips from Johnson & Johnson Vision ultraviolet expert Cristina Schnider, O.D.


More from Johnson & Johnson

Evarrest®: The little patch that can help surgeons in a big way

It may look deceptively simple, but this tool can help stop patients from bleeding during surgery.

3 nurse practitioners who are filling critical gaps in healthcare

From using cutting-edge technology to address mental health issues to launching an urban clinic that helps treat substance-abuse disorders and taking an innovative approach to deliver rural medical care, learn how Johnson & Johnson is helping support a new generation of providers.

What is a gene mutation?

Experts aren’t sure why, but sometimes changes in DNA can trigger cancer to grow and spread. Learn all about gene mutations—and Johnson & Johnson’s work developing new therapies to target these specific types of cancer.